(Total Views: 465)
Posted On: 10/07/2020 9:58:49 AM
Post# of 145890
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: CaptnAmerca #60132
From Lilly's PR: The combination therapy significantly reduced viral load at day 11 (p=0.011), meeting the primary endpoint of the study. Most patients, including those receiving placebo, demonstrated near complete viral clearance by day 11.
That's a head scratcher. Same as placebo but obtained stat significance?
That's a head scratcher. Same as placebo but obtained stat significance?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)